Tuberculosis treatment: exploring the perspectives for personalised therapy

The aim of this project is to explore pharmacogenomic biomarkers and to enable the progression of a personalised approach for tuberculosis (TB) patients. The work plan includes three WPs: (1) Collecting samples and assessing factors that could impact host responses to TB treatment; (2) Developing methodology for monitoring drug substances and main metabolites in blood samples; (3) Developing biomarker assays and screening of host biomarkers in TB patients.